Literature DB >> 26972487

Rapid isolation of pure Complement Factor H from serum for functional studies by the use of a monoclonal antibody that discriminates FH from all the other isoforms.

Silvia Berra1, Alberto Clivio2.   

Abstract

Several mutations have been identified in the gene coding for Complement Factor H (FH) from patients with atypical Hemolytic Uraemic Syndrome (aHUS), Age-related Macular Degeneration (AMD) and Membranoproliferative Glomerulonephritis (MPGN). These data allow for a precise description of the structural changes affecting FH, but a simple test for specifically assessing FH function routinely is not yet of common use. We have produced and characterised a monoclonal antibody (5H5) which discriminates between FH and the smaller FH-like 1 and FH-related proteins and show here that it specifically binds to FH without detecting the smaller isoforms. We therefore used this mAb for a quick, one-step micro-purification of FH directly from control sera and showed that this affinity chromatography procedure is not disruptive of its cofactor function. We also developed a modified sheep erythrocytes haemolysis test using our antibody and affinity-purified FH. These tests can be used in conjunction for assessing the function of FH purified from patients affected by FH-related diseases. Moreover we used this mAb to develop a FH-specific ELISA test.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Affinity chromatography; Complement Factor H; Functional assays; Immunoassays; Purification

Mesh:

Substances:

Year:  2016        PMID: 26972487     DOI: 10.1016/j.molimm.2016.03.001

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  3 in total

Review 1.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

2.  IgM Autoantibodies to Complement Factor H in Atypical Hemolytic Uremic Syndrome.

Authors:  Massimo Cugno; Silvia Berra; Federica Depetri; Silvana Tedeschi; Samantha Griffini; Elena Grovetti; Sonia Caccia; Donata Cresseri; Piergiorgio Messa; Sara Testa; Fabio Giglio; Flora Peyvandi; Gianluigi Ardissino
Journal:  J Am Soc Nephrol       Date:  2021-03-12       Impact factor: 10.121

3.  Complement Regulator FHR-3 Is Elevated either Locally or Systemically in a Selection of Autoimmune Diseases.

Authors:  Nicole Schäfer; Antje Grosche; Joerg Reinders; Stefanie M Hauck; Richard B Pouw; Taco W Kuijpers; Diana Wouters; Boris Ehrenstein; Volker Enzmann; Peter F Zipfel; Christine Skerka; Diana Pauly
Journal:  Front Immunol       Date:  2016-11-28       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.